Astrana Health, Inc.
S&P 600
$37.98
-0.13%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
No standout strengths flagged by the automated checks.
!Watch-points
- Higher leverage: debt-to-equity of 1.25 is above 1.
- Return on equity is on the lower side at 2.7%.
- Return on capital employed is on the lower side at 4.7%.
- Net profit margin is slim at 0.7%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.55
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Piotroski F-ScoreWeak
3 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$1.88B
Current Price$ 37.98
High / Low$ 51.60 / 18.08
Stock P/E46.317074
Book Value$ 16.68
Dividend Yield0%
ROCE4.71%
ROE2.71%
Debt to Equity1.25
Current Ratio1.40
P/B Ratio2.2520013
EPS$ 0.46
Debt$1.04B
PAT Margin0.71%
Cash PAT$68.24M
ICR1.57